Choose a language
Shortpedia Categories
Company
Download App




Single-dose vaccination for chikungunya found safe, effective in first phase three trial: Lancet Study

Shortpedia
Content Team
Image Credit: pixabay

A single-dose vaccine for chikungunya was found safe and produced a strong immune response against the viral disease, according to the first phase 3 trial of the preventive published in The Lancet journal. However, the researchers were unable to investigate whether the VLA1553 vaccine, developed by French biotech company Valneva, protects against subsequent disease since the study was not conducted in regions where chikungunya is endemic.


SMART CONTENT APP Hand picked content everyday

Shortpedia is a short news app which provide latest news in 70 words in Hindi or English Language. Read Breaking News on our Mobile App which is available on Google Play Store & Apple App Store.

Download App


Copyright © 2019 ShortPedia. All Rights Reserved.